Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annie Yang

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Molecular and Cellular Biology|November 26, 2002
A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanismZach Serber, Helen C Lai, Annie Yang, et al.
Msphere|January 3, 2024
Building-level wastewater surveillance localizes interseasonal influenza variationEmma R Germano, Tiffany Flores, Grace S Freed, et al.
Cancer Gene Therapy|June 10, 2021
CF33-hNIS-antiPDL1 virus primes pancreatic ductal adenocarcinoma for enhanced anti-PD-L1 therapyZhifang Zhang, Annie Yang, Shyambabu Chaurasiya, et al.
Plos One|August 21, 2015
High Transmitter CD4+ T-Cell Count Shortly after the Time of Transmission in a Study of African Serodiscordant CouplesEtienne Karita, Matt A Price, Shabir Lakhi, et al.
JMIR Mhealth and Uhealth|July 30, 2015
Mobile Phone-Connected Wearable Motion Sensors to Assess Postoperative MobilizationGeoff Appelboom, Blake E Taylor, Eliza Bruce, et al.
Haematologica|September 28, 2023
Polatuzumab vedotin plus bendamustine and rituximab or obinutuzumab in relapsed/refractory follicular lymphoma: a phase Ib/II studyChristopher R Flowers, Matthew J Matasar, Alex F Herrera, et al.
Molecular Therapy Oncolytics|March 23, 2022
Priming stroma with a vitamin D analog to optimize viroimmunotherapy for pancreatic cancerSang-In Kim, Shyambabu Chaurasiya, Venkatesh Sivanandam, et al.
Molecular Therapy. Methods & Clinical Development|January 13, 2022
A comprehensive preclinical study supporting clinical trial of oncolytic chimeric poxvirus CF33-hNIS-anti-PD-L1 to treat breast cancerShyambabu Chaurasiya, Annie Yang, Zhifang Zhang, et al.
Immunology and Cell Biology|September 7, 2011
ISCOMATRIX vaccines mediate CD8+ T-cell cross-priming by a MyD88-dependent signaling pathwayNicholas S Wilson, Becky Yang, Adriana Baz Morelli, et al.
Chemical Communications (Cambridge, England)|September 10, 2019
Anticancer organorhodium and -iridium complexes with low toxicity in vivo but high potency in vitro: DNA damage, reactive oxygen species formation, and haemolytic activityShahida Parveen, Muhammad Hanif, Euphemia Leung, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Molecular and Cellular Biology|November 26, 2002
A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanismZach Serber, Helen C Lai, Annie Yang, et al.
Msphere|January 3, 2024
Building-level wastewater surveillance localizes interseasonal influenza variationEmma R Germano, Tiffany Flores, Grace S Freed, et al.
Cancer Gene Therapy|June 10, 2021
CF33-hNIS-antiPDL1 virus primes pancreatic ductal adenocarcinoma for enhanced anti-PD-L1 therapyZhifang Zhang, Annie Yang, Shyambabu Chaurasiya, et al.
Plos One|August 21, 2015
High Transmitter CD4+ T-Cell Count Shortly after the Time of Transmission in a Study of African Serodiscordant CouplesEtienne Karita, Matt A Price, Shabir Lakhi, et al.
JMIR Mhealth and Uhealth|July 30, 2015
Mobile Phone-Connected Wearable Motion Sensors to Assess Postoperative MobilizationGeoff Appelboom, Blake E Taylor, Eliza Bruce, et al.
Haematologica|September 28, 2023
Polatuzumab vedotin plus bendamustine and rituximab or obinutuzumab in relapsed/refractory follicular lymphoma: a phase Ib/II studyChristopher R Flowers, Matthew J Matasar, Alex F Herrera, et al.
Molecular Therapy Oncolytics|March 23, 2022
Priming stroma with a vitamin D analog to optimize viroimmunotherapy for pancreatic cancerSang-In Kim, Shyambabu Chaurasiya, Venkatesh Sivanandam, et al.
Molecular Therapy. Methods & Clinical Development|January 13, 2022
A comprehensive preclinical study supporting clinical trial of oncolytic chimeric poxvirus CF33-hNIS-anti-PD-L1 to treat breast cancerShyambabu Chaurasiya, Annie Yang, Zhifang Zhang, et al.
Immunology and Cell Biology|September 7, 2011
ISCOMATRIX vaccines mediate CD8+ T-cell cross-priming by a MyD88-dependent signaling pathwayNicholas S Wilson, Becky Yang, Adriana Baz Morelli, et al.
Chemical Communications (Cambridge, England)|September 10, 2019
Anticancer organorhodium and -iridium complexes with low toxicity in vivo but high potency in vitro: DNA damage, reactive oxygen species formation, and haemolytic activityShahida Parveen, Muhammad Hanif, Euphemia Leung, et al.
Pageof 9